Tag Archives: David Kappos

Director Kappos “Chats” About PTO S.W.O.T.

Wednesday noon at the AIPLA 2010 Annual Meeting, USPTO Director David Kappos engaged in a “fireside chat” (actually podium-side chat) with AIPLA Executive Director and former PTO Director Q. Todd Dickinson about the Strengths, Weaknesses, Opportunities and Threats that he has … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , | Leave a comment

Defining the Abstract and Conceptual – USPTO Issues “Guidance” Post-Bilski

Before I write another word, I want to recognize and applaud the intellectual and logistical effort it must have taken for Director Kappos and his helpers to put together six pages of “Interim Guidance For Determining Subject Matter Eligibility for … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , | 1 Comment

Director Kappos Comments on Ariad v. Lilly

USPTO David Kappos recently posted a comment on the Fed. Cir. decision in Ariad v. Lilly in which he noted that the Fed. Cir. held that broad functional claims (presumably mechanism-of-action claims) must be supported by sufficient species (read “working examples”). While … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , | Leave a comment

David Kappos and The Impact of KSR – A Unique Opportunity For Our Profession

By Paul Cole Visiting Professor, Intellectual Property Law, Bournemouth University, UK On Tuesday 24 November, David Kappos made a posting on the Director’s Forum including the following statement: Some have suggested that the Office is determining obviousness in a way … Continue reading

Posted in Obviousness | Tagged , , , , , | Leave a comment